On Tuesday, Janux Therapeutics Inc (NASDAQ: JANX) was -3.17% drop from the session before settling in for the closing price of $61.56. A 52-week range for JANX has been $7.79 – $71.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 32.66% over the last five years. When this article was written, the company’s average yearly earnings per share was at -6.58%. With a float of $47.00 million, this company’s outstanding shares have now reached $52.34 million.
The firm has a total of 64 workers. Let’s measure their productivity. In terms of profitability, gross margin is 87.98%, operating margin of -658.76%, and the pretax margin is -463.91%.
Janux Therapeutics Inc (JANX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Janux Therapeutics Inc stocks. The insider ownership of Janux Therapeutics Inc is 18.68%, while institutional ownership is 78.35%. The most recent insider transaction that took place on Dec 03 ’24, was worth 1,005,000. In this transaction President and CEO of this company sold 15,000 shares at a rate of $67.00, taking the stock ownership to the 242,054 shares. Before that another transaction happened on Nov 25 ’24, when Company’s President and CEO sold 25,000 for $51.60, making the entire transaction worth $1,289,879. This insider now owns 257,054 shares in total.
Janux Therapeutics Inc (JANX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.58% per share during the next fiscal year.
Janux Therapeutics Inc (NASDAQ: JANX) Trading Performance Indicators
You can see what Janux Therapeutics Inc (JANX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 38.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 264.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -1.89 in one year’s time.
Technical Analysis of Janux Therapeutics Inc (JANX)
Analysing the last 5-days average volume posted by the [Janux Therapeutics Inc, JANX], we can find that recorded value of 0.94 million was better than the volume posted last year of 0.79 million. As of the previous 9 days, the stock’s Stochastic %D was 22.25%. Additionally, its Average True Range was 4.88.
During the past 100 days, Janux Therapeutics Inc’s (JANX) raw stochastic average was set at 67.47%, which indicates a significant increase from 61.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 184.30% in the past 14 days, which was higher than the 84.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $53.34, while its 200-day Moving Average is $46.71. Now, the first resistance to watch is $61.62. This is followed by the second major resistance level at $63.63. The third major resistance level sits at $64.96. If the price goes on to break the first support level at $58.28, it is likely to go to the next support level at $56.95. Should the price break the second support level, the third support level stands at $54.94.
Janux Therapeutics Inc (NASDAQ: JANX) Key Stats
There are 52,482K outstanding shares of the company, which has a market capitalization of 3.45 billion. As of now, sales total 8,080 K while income totals -58,290 K. Its latest quarter income was 440 K while its last quarter net income were -28,060 K.
